Nasopharyngeal carcinoma
- PMID: 26321262
- DOI: 10.1016/S0140-6736(15)00055-0
Nasopharyngeal carcinoma
Abstract
Epidemiological trends during the past decade suggest that although incidence of nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from the disease has fallen substantially. This finding is probably a result of a combination of lifestyle modification, population screening coupled with better imaging, advances in radiotherapy, and effective systemic agents. In particular, intensity-modulated radiotherapy has driven the improvement in tumour control and reduction in toxic effects in survivors. Clinical use of Epstein-Barr virus (EBV) as a surrogate biomarker in nasopharyngeal carcinoma continues to increase, with quantitative assessment of circulating EBV DNA used for population screening, prognostication, and disease surveillance. Randomised trials are investigating the role of EBV DNA in stratification of patients for treatment intensification and deintensification. Among the exciting developments in nasopharyngeal carcinoma, vascular endothelial growth factor inhibition and novel immunotherapies targeted at immune checkpoint and EBV-specific tumour antigens offer promising alternatives to patients with metastatic disease.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Nasopharyngeal carcinoma.Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178151 Review.
-
Nasopharyngeal carcinoma.Ann Oncol. 2010 Oct;21 Suppl 7:vii308-12. doi: 10.1093/annonc/mdq277. Ann Oncol. 2010. PMID: 20943634 Review.
-
Cigarette smoking complements the prognostic value of baseline plasma Epstein-Barr virus deoxyribonucleic acid in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy: a large-scale retrospective cohort study.Oncotarget. 2016 Mar 29;7(13):16806-17. doi: 10.18632/oncotarget.7609. Oncotarget. 2016. PMID: 26919237 Free PMC article.
-
Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.Chin Clin Oncol. 2016 Apr;5(2):18. doi: 10.21037/cco.2016.03.07. Chin Clin Oncol. 2016. PMID: 27121878 Review.
-
Risk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinoma.Oncotarget. 2016 Feb 23;7(8):9576-85. doi: 10.18632/oncotarget.7083. Oncotarget. 2016. PMID: 26840023 Free PMC article.
Cited by
-
Pinosylvin inhibits migration and invasion of nasopharyngeal carcinoma cancer cells via regulation of epithelial‑mesenchymal transition and inhibition of MMP‑2.Oncol Rep. 2021 Jul;46(1):143. doi: 10.3892/or.2021.8094. Epub 2021 Jun 3. Oncol Rep. 2021. PMID: 34080661 Free PMC article.
-
KIF9-AS1 promotes nasopharyngeal carcinoma progression by suppressing miR-16.Oncol Lett. 2020 Nov;20(5):241. doi: 10.3892/ol.2020.12104. Epub 2020 Sep 15. Oncol Lett. 2020. PMID: 32973955 Free PMC article.
-
Integrative analysis of miRNAs-mRNAs reveals that miR-182 up-regulation contributes to proliferation and invasion of nasopharyngeal carcinoma by targeting PTEN.Aging (Albany NY). 2020 Jun 15;12(12):11568-11578. doi: 10.18632/aging.103316. Epub 2020 Jun 15. Aging (Albany NY). 2020. PMID: 32541092 Free PMC article.
-
Nasopharyngeal carcinoma in Ibadan, Nigeria: a clinicopathologic study.Pan Afr Med J. 2020 Jun 9;36:82. doi: 10.11604/pamj.2020.36.82.19657. eCollection 2020. Pan Afr Med J. 2020. PMID: 32774641 Free PMC article.
-
Prevalence of Nasopharyngeal Carcinoma in Patients with Dermatomyositis: A Systematic Review and Meta-Analysis.Cancers (Basel). 2021 Apr 14;13(8):1886. doi: 10.3390/cancers13081886. Cancers (Basel). 2021. PMID: 33919987 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous